Navigation Links
Sigma-Aldrich Announces New Prestige Antibodies(TM) Line for Proteomics and Cell Biology Researchers
Date:2/14/2008

Sigma-Aldrich and Atlas Antibodies Establish Exclusive Distribution

Partnership

ST. LOUIS, Feb. 14 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced an exclusive partnership with Atlas Antibodies to distribute Prestige Antibodies(TM) -- developed by the Human Proteome Resource -- to the proteomics and cell biology research communities. Initially consisting of 1800 antibodies, the library is expected to grow by several thousand per year with the goal of producing at least one antibody to all 22,000 non-redundant human proteins by 2015. Through this partnership, Sigma-Aldrich is granted exclusive distribution rights in the U.S. and all regions outside of Europe, with co-exclusive distribution rights in Europe.

Prestige Antibodies(TM) are highly characterized and offer significant value to the research community. Each antibody is highly validated for specificity and accompanied by over 500 immunohistochemical images, which are displayed in the publicly accessible Human Protein Atlas. In addition, Prestige Antibodies(TM) are optimized on a single protocol and tailored for high throughput operations, providing significant time and cost savings for researchers. The antibodies are designed to have low cross-reactivity to other human proteins and to work in a variety of applications and tissue preparations. All Prestige Antibodies(TM) are tested in multiple assurance steps to ensure that they are the most specific products on the market.

"We are delighted to have been chosen as the exclusive distributor of Prestige Antibodies(TM), and we expect to release substantial additions to the catalog annually," said Dr. David Smoller, President of Sigma-Aldrich's Research Biotech business unit. "By making these high quality and highly validated antibodies accessible to proteomics and cell biology researchers worldwide, Sigma-Aldrich is helping to further promote the study of disease."

Atlas Ant
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...d,November24/PRNewswire-FirstCall/--deCODE,genetic...lofits,"firstday"motionsbytheU.S.BankruptcyCourtfo...DElastweekfiledavoluntarypetitionfor,reliefunderCh...ruptcyCourt. , TheordersissuedbytheBankruptcy...sduringtheChapter11proceedings.Inparticular,the,co...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasda...pingandcommercializingnovelpainmanagementtherapies...fExecutiveOfficer,isscheduledtopresentatthe21stAnn...er1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork...alOfficer,willbeavailabletorespondtoquestionsdurin...
(Date:11/24/2009)...RNewswire/--BlueMarbleEnergyCorp.announcedtodaytha...OPDA)wererecentlyawarded$2millionbyWashingtonState...vate/publicpartnershiptoconstructthestate,sfirstsp..., "Thisinvestmentwillsignificantlyspeedthedevel...colnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."W...
(Date:11/24/2009)...ndpointhasbeenmetforpatientswithadvanced-stage,orr...4/PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ...ticalcompanyfocusedonendocrinetherapyandoncology,t...ithitstargetedcytotoxicpeptideconjugate,AEZS-108(f...dometrialcancer.Inapersonalizedhealthcareapproach,...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
... FREMONT, Calif., Feb. 23 WaferGen Biosystems,Inc...of state-of-the-art gene,expression, genotyping, c...announced that the validation results of the compa...ted at Cambridge Healthcare Institute,s 16th,Inter...ata will be presented,by WaferGen scientists and c...
...HESDA, Md., Feb. 23 Micromet, Inc. (Nasdaq: M...l, proprietary antibodies for the treatment of can...nnounced that Dr. Kapil Dhingra has joined its Boa.... As a result of Dr. Dhingra,s appointment, the Bo...ngra has been active in oncology clinical research...
... iCardiac Continues to Succes... Offering , Rochester, Ne...ologies, Inc., a leading innovator in advanced car...oday announced that the company has experienced si...er revenues have grown in excess of 100%. Pharmac...
Other Biology Technology:Data on WaferGen's SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference 2Data on WaferGen's SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference 3Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors 2Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors 3Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors 4Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors 5iCardiac Reports Significant Revenue Growth and Profitability 2iCardiac Reports Significant Revenue Growth and Profitability 3
(Date:11/25/2009)...e California Institute of Technology (Caltech) hav...ehavior in the fruit fly, Drosophila melanogaster...e relationship between the neurotransmitter dopami...DHD), are described in the December issue of the j...ns only about 20,000 neurons and has long been con...
(Date:11/25/2009)... Cell Death Research Laboratory in the University ... the prestigious Johnson & Johnson Focused Funding...in cell damage in Parkinson,s disease. The award, ...t of innovation and excellence in science, was ann...his month at an event at the Hyatt Regency Hotel i...
(Date:11/25/2009)...e just as vital to your health as what you eat, fo...al Studies. Their experiments in mice revealed tha...s in the liverthe body,s metabolic clearinghouseis...ody,s circadian clock as conventional wisdom had i...f a large number of genes completely independent o...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Feeding the clock 2Feeding the clock 3Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia 4617 1Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia 4617 2Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia 4617 3Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia 4617 4Radiation Rescue 3A 4 Steps to Safeguard Your Family from the Other Inconvenient Truth The Health Hazards of Wireless Technology 49460 1Radiation Rescue 3A 4 Steps to Safeguard Your Family from the Other Inconvenient Truth The Health Hazards of Wireless Technology 49460 2Winner Medical to Benefit From the Increase of Tax Rebate Rate for Exports From China 49459 1Winner Medical to Benefit From the Increase of Tax Rebate Rate for Exports From China 49459 2Winner Medical to Benefit From the Increase of Tax Rebate Rate for Exports From China 49459 3
...HILL Researchers at the University of North Carol...he circadian clock the internal time-keeping mech...le can slow the progression of cancer. , The st...he field indicating that alteration of this daily ...NC researchers found that genetically altering one...
...GE, Mass., Feb. 3, 2009 -- Despite the striking ar... pine, a new mapping of the nose,s neural circuitr...rs for such disparate scents are as likely as not ...andom arrangement is faithfully preserved across i...ss the same scent located in precisely the same lo...
...hers at the Swiss Institute of Bioinformatics and ...h in Molecular Oncology in Lausanne have developed...respond to chemotherapy, which could help change h...icle, ,A stroma-related gene signature predicts re...cer, i, published in Nature Medicine , Dr Pierre ...
Other Biology News:UNC study: Tinkering with the circadian clock can suppress cancer growth 2UNC study: Tinkering with the circadian clock can suppress cancer growth 3Neural mapping paints a haphazard picture of odor receptors 2Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer 2Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer 3
Chromosomal Grade Agarose from Bio-Rad
DNA Engine Dyad Thermal Cycler Chassis from Bio-Rad
TRAPEZE® RT Telomerase Detection Kit from CHEMICON
Experion Pro260 Analysis Kit for 10 Chips from Bio-Rad
Biology Products: